The crisis in financing is having a chilling effect on biomedical innovation. As discussed in my last column, the main problem in our industry is that the sheer cost of drug development has become almost prohibitively expensive, effectively pricing almost everyone but the largest companies out of the market.

USIP has been engaged in serious and risky work, hand in hand with our military, in Iraq, Afghanistan and other trouble spots. It is engaged in mediation, nation building and other efforts to reduce conflict and save lives.

Physicians have watched in dismay as their role and status have devolved over the last several decades, from almost a relgious reverence to a level more commonly accorded to automobile mechanics.

Africa's most powerful state is flirting with a dangerous retreat into the all-too-crowded ranks of unserious, even odious, regimes that dot the continent.

Democrats in Congress have asked the "Big Three" domestic automakers to provide a plan by early December that would return the auto industry to profitability.

Government rebates on domesticcars would do less harm than a bailout of the Big Three automakers.

If Gitmo's prisoners are innocent goatherds, as many claim, why are their alibis so lame?

Health inequalities are best resolved by pluralistic social processes that facilitate, but do not mandate, more effective choices and trade-offs.